|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV040401529 |
| 003 |
DE-627 |
| 005 |
20230625231748.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2017 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.pcd.2017.05.008
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2017009000027.pica
|
| 035 |
|
|
|a (DE-627)ELV040401529
|
| 035 |
|
|
|a (ELSEVIER)S1751-9918(17)30084-0
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 630
|q VZ
|
| 082 |
0 |
4 |
|a 640
|q VZ
|
| 082 |
0 |
4 |
|a 590
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 600
|q VZ
|
| 084 |
|
|
|a 50.70
|2 bkl
|
| 100 |
1 |
|
|a Goderis, Geert
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Factors associated with Prolonged Inaction in the hypoglycaemic treatment in people with non-insulin dependent Type 2 Diabetes and elevated glycated haemoglobin: A registry-based cohort study
|
| 264 |
|
1 |
|c 2017transfer abstract
|
| 300 |
|
|
|a 8
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a • Prolonged Inaction (PI) is defined as the absence of antidiabetic treatment adjustments in spite of indications based on patients’ HbA1c values. • PI which is the sum of ‘True’ and ‘False’ Clinical Inertia is useful to evaluate patients’ trajectories based on routinely collected data. • PI in primary care is associated with both outcome indicators (lower values HbA1c values) and process indicators (higher frequency in the follow-up). • The trigger to initiate antidiabetic treatment changes in ‘real practice’ remains 7.5% or even 8%, instead of 7%. • Co-morbidities interact in a complex way, eitherer fostering PI (e.g. CKD) or fostering treatment intensification (e.g. depression).
|
| 520 |
|
|
|a • Prolonged Inaction (PI) is defined as the absence of antidiabetic treatment adjustments in spite of indications based on patients’ HbA1c values. • PI which is the sum of ‘True’ and ‘False’ Clinical Inertia is useful to evaluate patients’ trajectories based on routinely collected data. • PI in primary care is associated with both outcome indicators (lower values HbA1c values) and process indicators (higher frequency in the follow-up). • The trigger to initiate antidiabetic treatment changes in ‘real practice’ remains 7.5% or even 8%, instead of 7%. • Co-morbidities interact in a complex way, eitherer fostering PI (e.g. CKD) or fostering treatment intensification (e.g. depression).
|
| 650 |
|
7 |
|a Clinical Inertia
|2 Elsevier
|
| 650 |
|
7 |
|a Type 2 Diabetes Mellitus
|2 Elsevier
|
| 650 |
|
7 |
|a Retrospective cohort study
|2 Elsevier
|
| 650 |
|
7 |
|a Oral anti-diabetic treatment
|2 Elsevier
|
| 700 |
1 |
|
|a Vaes, Bert
|4 oth
|
| 700 |
1 |
|
|a Van den Akker, Marjan
|4 oth
|
| 700 |
1 |
|
|a Elli, Steven
|4 oth
|
| 700 |
1 |
|
|a Mathieu, Chantal
|4 oth
|
| 700 |
1 |
|
|a Buntinx, Frank
|4 oth
|
| 700 |
1 |
|
|a Henrard, Séverine
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
| 773 |
1 |
8 |
|g volume:11
|g year:2017
|g number:5
|g pages:482-489
|g extent:8
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2017.05.008
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 11
|j 2017
|e 5
|h 482-489
|g 8
|
| 953 |
|
|
|2 045F
|a 610
|